Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyvalent metal cations are positively charged metal ions with a valence of +2 or higher, including essential physiological ions like calcium, magnesium, and iron, as well as toxic elements like lead and aluminum (NIH, 2023). These ions are fundamental to biological life, serving as critical cofactors for over 30% of all enzymes, maintaining the structural integrity of the skeletal system, and acting as secondary messengers in cellular signaling pathways (UniProt; NIH Office of Dietary Supplements). In clinical pharmacology, polyvalent metal cations are targeted by chelating agents such as deferoxamine and penicillamine to treat metal overload diseases like hemochromatosis and Wilson's disease, or to mitigate heavy metal poisoning (PubChem; Mayo Clinic). Additionally, they are a major source of pharmacokinetic drug-drug interactions; they can bind to and form insoluble complexes with various oral medications, including fluoroquinolones, tetracyclines, and integrase inhibitors, thereby significantly reducing their absorption and therapeutic efficacy (FDA; StatPearls). Consequently, the timing of administration for drugs and cation-containing supplements or antacids must be carefully managed to avoid treatment failure (StatPearls).
Chelation and complexation; therapeutic agents (chelators) bind these cations to form stable, water-soluble complexes for excretion (PubChem), while certain other drugs (e.g., antibiotics) form insoluble complexes with these cations in the gut, which inhibits drug absorption (FDA; StatPearls).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyvalent metal cation.